Proteomics Market worth $67.55 billion by 2031
The report "Proteomics Market by Instrumentation (Mass Spectrometry, HPLC, Electrophoresis, Protein Microarray), Reagents, Services (Core, Bioinformatics), Software, Workflow (Sample Prep, Separation), Applications, End User, Competition - Global Forecast to 2031" is expected to reach USD 67.55 billion in 2031 from USD 39.84 billion in 2026, at a CAGR of 11.1% during the forecast period.
Browse 950 market data Tables and 50 Figures spread through 750 Pages and in-depth TOC on "Proteomics Market by Instrumentation (Mass Spectrometry, HPLC, Electrophoresis, Protein Microarray), Reagents, Services (Core, Bioinformatics), Software, Workflow (Sample Prep, Separation), Applications, End User, Competition - Global Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/proteomics-market-731.html
The proteomics market is experiencing significant growth, driven by advancements in high-throughput mass spectrometry and data-independent acquisition workflows, increasing use of proteomics in biomarker discovery and translational diagnostics, and rising integration with multi-omics research. Pharmaceutical and biotechnology companies are increasingly incorporating proteomics into drug discovery, disease profiling, and precision medicine strategies to generate deeper protein-level insights. The growing focus on clinical proteomics, plasma proteomics, and automation-enabled workflows is further supporting market expansion. However, the market continues to face challenges such as the high capital intensity of advanced proteomics platforms, the complexity of proteomics data analysis, and limited standardization across workflows, which may restrict broader adoption and clinical translation.
By service, the core proteomics services segment held the largest share of the proteomics market in 2025.
By service, the proteomics market is segmented into core proteomics services and bioinformatics services. In 2025, core proteomics services accounted for the largest market share. This is primarily attributed to the high demand for outsourced protein identification, quantification, biomarker discovery, post-translational modification analysis, and mass spectrometry-based profiling services across pharmaceutical, biotechnology, and academic research settings. The growing use of proteomics in drug discovery, translational research, and clinical biomarker studies has increased reliance on specialized service providers with advanced analytical infrastructure and technical expertise. Additionally, the need for high-quality, reproducible, and turnaround-efficient protein analysis continues to support the dominance of the core proteomics services segment.
By software, the bioinformatics tools segment held the largest share of the proteomics market in 2025.
By software, the proteomics market is segmented into bioinformatics tools and bioinformatics databases. In 2025, bioinformatics tools accounted for the largest market share. This is due to the increasing need for software solutions that support protein identification, peptide mapping, quantification, pathway analysis, spectral interpretation, and multi-omics data integration. As proteomics datasets become more complex and high-throughput workflows become more common, researchers and laboratories are increasingly dependent on analytical tools that improve data processing speed, accuracy, and interpretation. Furthermore, the rising adoption of AI-enabled and workflow-integrated analysis platforms continues to strengthen the position of the bioinformatics tools segment in the market.
By region, North America accounted for the largest share of the market in 2025.
In 2025, North America held the largest share of the proteomics market. This is supported by a strong biopharmaceutical base, rapid adoption of advanced mass spectrometry and protein analysis platforms, and high investment in biomarker discovery and translational research. The US leads the region in research funding, innovation, and early adoption of clinical and multi-omics proteomics workflows. The presence of major market players, proteomics-focused research institutions, clinical laboratories, and established academic-industry collaborations continues to drive demand across research and diagnostic applications. Ongoing advancements in precision medicine, cancer biomarker research, and clinical proteomics are further supporting market growth in North America.
Some of the leading players in the market include Thermo Fisher Scientific Inc. (US), Agilent Technologies, Inc. (US), Merck KGaA (Germany), Danaher Corporation (US), Shimadzu Corporation (Japan), Waters Corporation (US), Bio-Rad Laboratories, Inc. (US), Bruker (US), Revvity (US), and Illumina, Inc. (US), among others.
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: [email protected]
Visit Our Website: https://www.marketsandmarkets.com
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Proteomics Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
